Merck and Co Inc is closing its Merck Frosst Centre for Therapeutic Research as part of a global restructuring prompted by its 2009, US$41-billion acquisition of Schering-Plough. The centre is one of eight research centres worldwide that are being shuttered as the Whitehouse Station NJ-based firm sheds 15,000 people or 15% of its work force.